United Therapeutics Corp (UTHR)
262.33
+4.22
(+1.63%)
USD |
NASDAQ |
May 03, 16:00
262.33
0.00 (0.00%)
After-Hours: 20:00
United Therapeutics Cash from Operations (Quarterly): 376.50M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 376.50M |
| December 31, 2023 | 150.70M |
| September 30, 2023 | 346.20M |
| June 30, 2023 | 106.30M |
| March 31, 2023 | 374.80M |
| December 31, 2022 | 128.20M |
| September 30, 2022 | 258.60M |
| June 30, 2022 | 127.00M |
| March 31, 2022 | 288.70M |
| December 31, 2021 | 174.60M |
| September 30, 2021 | 185.60M |
| June 30, 2021 | 148.20M |
| March 31, 2021 | 89.80M |
| December 31, 2020 | 126.20M |
| September 30, 2020 | 250.90M |
| June 30, 2020 | 164.00M |
| March 31, 2020 | 214.60M |
| December 31, 2019 | 102.50M |
| September 30, 2019 | 185.40M |
| June 30, 2019 | 132.90M |
| March 31, 2019 | -627.40M |
| December 31, 2018 | 85.40M |
| September 30, 2018 | 237.50M |
| June 30, 2018 | 179.80M |
| March 31, 2018 | 275.70M |
| Date | Value |
|---|---|
| December 31, 2017 | -85.80M |
| September 30, 2017 | 258.50M |
| June 30, 2017 | 70.70M |
| March 31, 2017 | 230.80M |
| December 31, 2016 | 163.40M |
| September 30, 2016 | 228.70M |
| June 30, 2016 | 125.70M |
| March 31, 2016 | 125.80M |
| December 31, 2015 | 25.50M |
| September 30, 2015 | 207.20M |
| June 30, 2015 | 41.00M |
| March 31, 2015 | 109.10M |
| December 31, 2014 | 90.65M |
| September 30, 2014 | 208.54M |
| June 30, 2014 | -54.48M |
| March 31, 2014 | 110.60M |
| December 31, 2013 | 104.42M |
| September 30, 2013 | 139.30M |
| June 30, 2013 | 83.85M |
| March 31, 2013 | 97.70M |
| December 31, 2012 | 105.21M |
| September 30, 2012 | 93.45M |
| June 30, 2012 | 87.39M |
| March 31, 2012 | 37.58M |
| December 31, 2011 | 51.63M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
89.80M
Minimum
Mar 2021
376.50M
Maximum
Mar 2024
196.58M
Average
169.30M
Median
Cash from Operations (Quarterly) Benchmarks
| Liquidia Corp | -15.98M |
| Esperion Therapeutics Inc | -37.06M |
| Vertex Pharmaceuticals Inc | 234.60M |
| Heron Therapeutics Inc | 2.455M |
| Aldeyra Therapeutics Inc | 0.5004M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 735.30M |
| Cash from Financing (Quarterly) | -1.068B |
| Free Cash Flow | 752.40M |
| Free Cash Flow Per Share (Quarterly) | 6.807 |
| Free Cash Flow to Equity (Quarterly) | 438.30M |
| Free Cash Flow to Firm (Quarterly) | 338.30M |
| Free Cash Flow Yield | 5.77% |